PharmaCyte Biotech Successfully Completes Final Pre-Production Run of Pancreatic Cancer Product
LAGUNA HILLS, CA, September 18, 2018 (BUSINESS WIRE) — PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that its partner, Austrianova, has successfully performed an additional pre-production “engineering
Read more →
